Table 1.
Parameters | AFP-Negative Patients With HCC | AFP-negative Patients With HCC | Healthy Controls | P1/P2 |
---|---|---|---|---|
n = 171 | n = 60 | n = 102 | ||
WBC | 6.81 (3.50) | 6.33 (2.73) | 6.18 (1.26) | .931/.168 |
MPV, fL | 9.31 (1.51) | 9.35 (1.59) | 8.59 (0.97) | <.0001/.006 |
RDW, % | 14.67 (2.70) | 15.80 (3.73) | 13.07 (0.64) | <.0001/<.0001 |
MPV–PC ratio | 0.069 (0.043) | 0.071 (0.033) | 0.041 (0.012) | <.0001/<.0001 |
NLR | 5.32 (5.17) | 4.24 (4.43) | 1.83 (0.73) | <.0001/<.0001 |
PLR | 168.97 (115.24) | 152.13 (93.98) | 114.99 (40.73) | <.0001/.007 |
Abbreviations: HCC, hepatocellular carcinoma; MPV, mean platelet volume; MPV/PC ratio, mean platelet volume to platelet count ratio; NLR, neutrophil to lymphocyte ratio; PC, platelet count; PLR, platelet to lymphocyte ratio; P1, P value of comparing AFP-negative HCC patients with Healthy controls; P2, P value of comparing AFP-positive HCC patients with Healthy controls; RDW, red blood cell distribution width; SD, Standard deviation; WBC, White blood cell.
a Hematological parameters are expressed as mean (SD);